Related Experiment Video
Updated: May 27, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Long-term efficacy and safety of a generic atorvastatin in usual clinical care setting
L M Ong1, N Punithavathi, Y L L Lena
1Penang Hospital.
Abstract:
A multicentre study was conducted to assess the long term efficacy and safety of a generic atorvastatin in the treatment of primary hypercholesterolaemia. Eighty five patients who received 10mg or 20 mg of atorvastatin for 8 weeks depending on target cholesterol goal were followed up by their own physicians and had final evaluation at 52 weeks. Reduction in mean low density Lipoprotein (LDL-C) was 36.5%, 37.9% and 32.2% at weeks 4, 8 and 52 respectively. LDL-C target was maintained in 81% and 69% of patients at week 8 and 52 respectively without drug related serious adverse events. Generic atorvastatin is safe and effective in usual clinical care setting.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Bioavailability Study Design: Healthy Subjects Versus Patients
Atherosclerosis III: Management
Clinically Relevant Drug Product Specifications: Methods of Establishment